Learn more: scim.ag/3FXN8sq
Learn more: scim.ag/3FXN8sq
www.qmul.ac.uk/bcsc/events/...
www.qmul.ac.uk/bcsc/events/...
www.nature.com/articles/d41...
www.nature.com/articles/d41...
Read Coulombe et al's News & Perspective Commentary in the April issue.
doi.org/10.1016/j.ji...
#DermatologyJournal #dermatology #dermsky #dermatologists #dermresearch #dermscience #dermatologyresearch
Read Coulombe et al's News & Perspective Commentary in the April issue.
doi.org/10.1016/j.ji...
#DermatologyJournal #dermatology #dermsky #dermatologists #dermresearch #dermscience #dermatologyresearch
https://go.nature.com/4iJSgy5
https://go.nature.com/4iJSgy5
There’s still time to apply for the LMB’s Student Placement Scheme.
Visit our website to learn more and get your applications in by 30th March.
www2.mrc-lmb.cam.ac.uk/students/stu...
There’s still time to apply for the LMB’s Student Placement Scheme.
Visit our website to learn more and get your applications in by 30th March.
www2.mrc-lmb.cam.ac.uk/students/stu...
tinyurl.com/54faf7kv
Alice Shaw of the Dana-Farber Cancer Institute discusses the newly launched Center for RAS Therapeutics and the key role of combination strategies in building on the initial breakthroughs with RAS inhibitors
@danafarber.bsky.social
tinyurl.com/54faf7kv
Alice Shaw of the Dana-Farber Cancer Institute discusses the newly launched Center for RAS Therapeutics and the key role of combination strategies in building on the initial breakthroughs with RAS inhibitors
@danafarber.bsky.social
"It hurts," they told me.
My story for @nature.com 🧪
www.nature.com/articles/d41...
"It hurts," they told me.
My story for @nature.com 🧪
www.nature.com/articles/d41...
Watch the video: https://go.nature.com/3Dt4pIt 🧪 🏺
Watch the video: https://go.nature.com/3Dt4pIt 🧪 🏺
🧪 #academicSky #ECRs
@nature.com
www.nature.com/articles/d41...
🧪 #academicSky #ECRs
@nature.com
www.nature.com/articles/d41...